Comparison between Sadhav Shipping IPO and Zenith Drugs IPO.
Sadhav Shipping IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Zenith Drugs IPO is a SME Bookbuilding proposed to list at NSE SME.
| Sadhav Shipping IPO | Zenith Drugs IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | ISK Advisors Pvt.Ltd. | Gretex Corporate Services Ltd. |
| Registrar | Maashitla Securities Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Sunflower Broking Pvt.Ltd. | Gretex Share Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Sadhav Shipping IPO is up to ₹36.25 Cr whereas the issue size of the Zenith Drugs IPO is up to ₹33.94 Cr. The final issue price of Sadhav Shipping IPO is ₹95.00 per share and of Zenith Drugs IPO is ₹79.00 per share.
| Sadhav Shipping IPO | Zenith Drugs IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹75.00 per share | |
| Issue Price (Upper) | ₹79.00 per share | |
| Issue Price (Final) | ₹95.00 per share | ₹79.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1200 shares | 1600 shares |
| Fresh Issue Size | 38,16,000 shares | 42,96,000 shares |
| Fresh Issue Size (Amount) | up to ₹36.25 Cr | up to ₹33.94 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 38,16,000 shares | 42,96,000 shares |
| Issue Size Total (Amount) | up to ₹36.25 Cr | up to ₹33.94 Cr |
Sadhav Shipping IPO opens on Feb 23, 2024, while Zenith Drugs IPO opens on Feb 19, 2024. The closing date of Sadhav Shipping IPO and Zenith Drugs IPO is Feb 27, 2024, and Feb 22, 2024, respectively.
| Sadhav Shipping IPO | Zenith Drugs IPO | |
|---|---|---|
| Anchor Bid Date | Feb 16, 2024 | |
| Issue Open | Feb 23, 2024 | Feb 19, 2024 |
| Issue Close | Feb 27, 2024 | Feb 22, 2024 |
| Basis Of Allotment (Tentative) | Feb 28, 2024 | Feb 23, 2024 |
| Initiation of Refunds (Tentative) | Feb 29, 2024 | Feb 26, 2024 |
| Credit of Share (Tentative) | Feb 29, 2024 | Feb 26, 2024 |
| Listing date (Tentative) | Mar 01, 2024 | Feb 27, 2024 |
| Anchor Lockin End date 1 | Mar 24, 2024 | |
| Anchor Lockin End date 2 | May 23, 2024 |
Sadhav Shipping IPO P/E ratio is 12.66, as compared to Zenith Drugs IPO P/E ratio of 18.4.
| Sadhav Shipping IPO | Zenith Drugs IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Sadhav Shipping Limited Financial Information (Restated)Sadhav Shipping Limited's revenue increased by 13.08% and profit after tax (PAT) rose by 157.68% between the financial year ending with March 31, 2023 and March 31, 2022.
| Zenith Drugs Limited Financial Information (Restated Consolidated)Zenith Drugs Limited's revenue increased by 24.85% and profit after tax (PAT) rose by 64.7% between the financial year ending with March 31, 2023 and March 31, 2022.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 96.44 | 100.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 69.44 | 69.98 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 12.66 | 18.4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹136.35 Cr. | ₹135.48 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 20.41% | 35.13% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 14.36% | 37.29% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.51 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹7.50 | ₹4.29 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 18.94% | 29.88% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Sadhav Shipping IPO Retail Individual Investors (RII) are offered 19,08,000 shares while in Zenith Drugs IPO retail investors are offered 19,08,000 shares. Qualified Institutional Buyers (QIB) are offered in Sadhav Shipping IPO and 8,59,200 shares in Zenith Drugs IPO.
| Sadhav Shipping IPO | Zenith Drugs IPO | |
|---|---|---|
| Anchor Investor Reserveration | 12,88,000 shares | |
| Market Maker Reserveration | 2,02,800 shares | 8,52,800 shares |
| QIB | 8,59,200 shares | |
| NII | 19,08,000 shares | 6,44,800 shares |
| RII | 19,08,000 shares | 15,04,000 shares |
| Employee | ||
| Others | ||
| Total | 38,16,000 shares | 42,96,000 shares |
Sadhav Shipping IPO subscribed 135.69x in total, whereas Zenith Drugs IPO subscribed 179.18x.
| Sadhav Shipping IPO | Zenith Drugs IPO | |
|---|---|---|
| QIB (times) | 106.72x | |
| NII (times) | 184.58x | 368.77x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 65.52x | 139.28x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 135.69x | 179.18x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
